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Abstract 
Background: The purpose of this study was to determine the effectiveness of cognitive-behavioral stress 
therapy on stress, depression and distress in patients with cancer. 
Cases Report: In a cross-sectional study of consecutive patients (Aged 32-70 years, progression of their 
disease was at levels 1 to 3, high cycle education, and 3 months of chemotherapy, of which 40, were randomly 
available from this group (20 experimental and 20 Control group). The instrument was a McGill Pain 
Questionnaire (1997) and the Hazards and Anxiety and Depression Scale (HADS) questionnaire. Data were 
analyzed using two methods of Kolmogorov-Smirnov inferential statistics and multivariate analysis of 
covariance using software software Spss17. 
Conclusion: Correlation analysis showed that the experimental group had a significant reduction in depression 
and anxiety in the posttest after the control group compared with the control group. The short-term cognitive-
behavioral stress management program can reduce, depression and anxiety in cancer patients. 
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Cancer diagnosis is a significant source of 
psychological stress/distress (hereinafter referred to 
as stress), followed by an extended period of stressful 
cancer treatment1. 
Mood disturbance, particularly of depression and 
anxiety, is common with cancer diagnosis and has 
been highly. 
 The increase of the rate of survival can be attributed 
to the progressively more aggressive treatment 
procedures and protocols. However, this increased 
survival rate has resulted in some chronic issues for 
many of these patients. There has also been an 
increase in the incidence of side effects and reduced 
quality of life during and after treatment of cancer2.  
With the rising incidence of cancer survivors and 
pediatric oncology patients, pain is a major priority of 
care. 
Considerable data suggest that depression and anxiety 
are the most commonly studied mood disorders, but 
that the rates of depression vary (10–20%) as reported 
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in a review by3. Another study suggests, however, 
that the number of patients with depression or 
anxiety is closer to 50% in the first year4, and a 
recent study reported that 35% still experience 
increased distress at 5year follow-up5. Although 
underlying methodological differences in the studies 
may contribute to these diverse findings, it is 
undisputed that a significant minority of women 
experience serious adjustment problems after the 
treatment for cancer6. The prevalence of clinically 
diagnosed depression based on the Diagnostic and 
Statistical Manual of Mental Disorder, 4th edition 
(DSM-IV) criteria was estimated at 18.3% among all 
U.S. cancer survivors. Frequency of depression may 
vary by cancer  and treatment received7. Cancer 
survivors experience a heavy financial burden during 
treatment and can still feel financial pressure long 
after the initial active treatment end8. Furthermore, 
financial burden and depression can be bi 
directionally associated9. Depression tends to be a 
cyclical, chronic illness and, once depressed, 
individuals are at risk to have another depression 
episode as they move through life10. Since many 
cancer survivors report depression after their cancer 
diagnosis, during, and soon after active treatment11, 
how this depression is associated with financial 
pressures over the long term remains unexplored.  
Further investigation of the effect of cancer types, 
treatments, and depression on survivors’ financial 
well-being is needed. Pain is one of the most 
distressing aspects of suffering related to cancer 
treatment.  With new technology and treatment 
modalities, pediatric cancer patients have a better 
chance of surviving, however pain is still a major 
side effect of treatment12.  The increase of the rate of 
survival can be attributed to the progressively more 
aggressive treatment procedures and protocols. 
However, this increased survival rate has resulted in 
some chronic issues for many of these patients.  
There has also been  an increase in the incidence of 
side effects and reduced quality of life during and after 
treatment  of cancer13.  CBT is the most frequently 
used approach in studying the effects of psychological 
intervention in adjustment to cancer14-16, and its value 
has been demonstrated in reducing distress with 
diverse cancer populations17. Tatrow and Montgomery 
(2006) have highlighted that CBT is particularly 
beneficial for breast cancer patients with respect to 
their short-term effects on depression, anxiety and 
quality of life. stress management interventions may 
not be effective or necessary for all patients, and so, it 
is essential to identify subgroups of participants who 
benefit most. A meta-analysis by Schneider et al. 
(2010) showed that pre-intervention distress 
significantly moderated effects with the most 
distressed participants showing better adjustment. 
Other studies have shown that interventions may be 
differentially effective depending on baseline 
differences in optimism18, social support19 and cancer-
specific stress20. Identification of the women most in 
need of intervention remains an ongoing research and 
health care issue14,21. 
Case Report 
The statistical population of the study included cancer 
patients with males and females who referred to Tabriz 
Shohada Hospital in Tehran (age 32-70 years, 
progression of their disease at levels 1 to 3, higher 
education in chemistry and 3 months of chemistry 
They were treated with 40 patients randomly (20 
experimental and 20 control groups) selected from the 
available sampling method. The instrument was the 
Anxiety and Depression Scale (HADS) questionnaire. 
Data were analyzed using descriptive and inferential 
statistics. In the descriptive section, we used the 
frequency distribution of the table and the mean and 
standard deviations and in the inferential statistics of 
the Kolmogorov-Smirnov tests and multivariate 
covariance analysis using Spss17 software. 
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Hospital Anxiety and Depression Inventory 
(HADS): The HADS was designed to provide a 
practical tool to identify and quantify the two most 
common forms of psychological disorders, 
depression, and anxiety. It was used initially in 
patients who had been in clinical psychiatric 
hospitals, and then extended to evaluate a non-
hospitalized patient with some type of disease or 
individuals without disease. HADS does not consider 
vegetative symptoms associated with depression and 
anxiety, and it does not allow interferences of 
somatic symptoms in the assessment. HADS consists 
of a 14-item self-report questionnaire incorporating 
seven questions for anxiety and seven others for 
depression. The seven questions about depressive 
symptoms comprise the Depression Subscale of 
Hospital Anxiety and Depression Scale. Each item is 
scored 0 to 3, and a total score of 8 or greater on one 
or both subscales indicates the presence of a 
depressive or anxiety disorder. HADS was translated 
and validated for the Brazilian-Portuguese language, 
by Botega. HADS has been used as a screening 
questionnaire in patients before the spine surgery. 
As shown in the table, the data obtained from the 
implementation of the normal distribution anxiety 
questionnaire (Kolmogorov-Smirnov test is not 
significant in the significant difference). Therefore, the 
default is the normal distribution of data. Default 
homogeneity of variances: Homogeneous assumption 
of variance of anxiety variables was investigated. 
Using Loon's test, the results of this test are presented 
in Table 2. 
Results show that the Loonens test is meaningful 
(P=0.112, F=2.469), which indicates that the variances 
are homogeneous Therefore, the covariance analysis 
test can be used to compare the anxiety posttest. The 
results of covariance analysis are presented in Table 3. 
To test the homogeneity of regression coefficients, we 
use the f test. According to the results of Table 3, the F 
test for the homogeneity of regression coefficients is 
not significant in the study variable. To examine the 
coexistence of the two groups in the baseline, 
independent t test was used. 
Regarding the results of Table 4, independent t values 
are not significant for the anxiety of cancer patients. 
Therefore, the two groups are peers in the base line. 
As shown in the table 3, the results obtained from the 
comparison of the post-test of anxiety variable in the 
two groups by controlling the pre-test effect indicate 
that after the behavioral cognitive behavioral stress 
management, the anxiety scores in cancer patients who 
participated in the test group had a ratio. There was a 
significant decrease in those who were replaced in the 
control group (P <0.05, F = 6.400). So hypothesis. 
First, the research is confirmed. Therefore, cognitive-
behavioral stress management is effective on the 
anxiety of people with cancer. Eta's coefficient shows 
that 14% decrease in anxiety in cancer patients in the 
experimental group because of cognitive behavioral 
stress management by the researcher. That results with 
results. 
As shown in the table 6, the data obtained from the 
implementation of the depression questionnaire have a 
normal distribution (Kolmogorov-Smirnov test is not 
Table 1: Kolmogorov-Smirnov test to ensure the 
normal distribution of anxiety scales. 
variable Kolmogorov-Smirnov Sig 
Anxiety 0.953 0.323 
 
 
Table 2: Leven test to ensure homogeneity of 
variance of anxiety variables. 
variable F Df1 Df2 Sig 
Anxiety 2.649 1 38 0.112 
 
 
Table 3: Regression slope survey to ensure 
homogeneity of regression coefficients of anxiety 
variable. 
Source F           Sig 
Anxiety * Pre-test 16.787 0.35 
 
 
Table 4: Results of analysis of variance for the mean 
scores of post-test anxiety in the experimental and 
control group. 
variable t Df  Sig 
Anxiety 
1.28 38 0.483 
 
 
Asadbeygi et al.                         Assessing the effectiveness of cognitive behavioral stress management (CBSM) on anxiety … 
NBM                                                                            102                                   Novelty in Biomedicine 2018, 2, 99-104 
significant in the depression variable). Therefore, the 
default is the normal distribution of data. Pre-
homogeneity of variances: the homogeneous 
assumption of variables of depression was 
investigated using Leven's test. The results of this 
test are presented in the Table 7. 
As can be seen, the results showed that the Loonse 
test was not significant (P=0.120, F=2.527), which 
indicates that the variances are homogeneous. 
Therefore, the covariance analysis test can be applied 
to compare post-test depression. The results of 
covariance analysis are presented in the Table 8 
To test the homogeneity of regression coefficients, 
we use the f test. 
According to the results of Table 8, the test is not 
significant for convergence of regression coefficients 
in the study variable. Therefore, assuming that the 
regression coefficients are homogeneous, analysis of 
the covariance is made. 
Independent t test was used to examine the co-
existence of the two groups in the base line. 
According to the results of the Table 9 the independent 
value of t is not meaningful for the depression of 
cancer patients. Therefore, the two groups are peer in 
the base line. 
Table 10 Results of covariance analysis on the mean 
scores of post-test depression in the experimental and 
control group. 
As shown in the Table 9, the results of the comparison 
of the post-test variable of depression in the two 
groups by controlling the pre-test effect indicate that 
after cognitive behavioral intervention, depression 
stress management in cancer patients who participated 
in the experimental group, Had a significant decrease 
compared to those in the control group (P<0.05, 
F=3.881). 
Therefore, the second hypothesis of the research is 
confirmed. Therefore, cognitive-behavioral stress 
management has been effective on the prevalence of 
people with cancer. 
The Eta-0.39 coefficient shows that cognitive-
Table 6: Kolmogorov-Smirnov test to ensure the 
normal distribution of variable depression scores. 
variable Kolmogorov-Smirnov Sig 
Depression 0.864 0.445 
 
 
Table 5: Comparison of post-test anxiety in two groups with control of pre-test control effect. 
Source Df Mean Square F P-value Partial Eta Squared    
Pre-test 1 45.653 31.813 0.000 0.462   
       
Group 1 9.184 6.400 0.016 0.147   
       
Error 37 1.435     
Total 40      
 
 
Table 7: Leven test to ensure the homogeneity of 
variables of depression. 
Variable F Df1  Df2  Sig 
Depression 2.527 1 38 0.120 
 
 
Table 8: Regression slope check to ensure 
homogeneity of regression coefficients of depression 
variable. 





 Table 9: Independent t test. 
variable t Df    Sig 
Depression 1.160 38 0.630 
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behavioral cognitive behavioral instruction has a 
significant effect on decreasing depression. 
Discussion 
The eight-week, five-contact intervention was 
designed to assist patients with identifying 
troublesome symptoms, generating intervention 
strategies to decrease symptom severity, and 
evaluating the effectiveness of the strategies In our 
study, we found that coping strategies were 
associated with pain intensity and quality. 
Data suggest that patients with advanced disease 
undergoing chemotherapy are able to successfully 
implement problem-solving strategies that reduce the 
severity of symptoms. The results of this study 
extend the work of other investigators who have 
reported on the effectiveness of CBTM in decreasing 
the severity of specific symptoms22. 
This study provides clear evidence that a briefer than 
the norm group-based stress management 
intervention can produce significant improvements in 
adjustment in undergoing treatment for non-
metastatic cancer. Mood disturbance, including 
depression and anxiety, has been highly correlated 
with psychological stress and, as a result, mood 
disturbance has been used frequently to indicate 
psychological stress23,24. The intervention 
significantly reduced perceived global stress (primary 
outcome) post-treatment anxiety, depression. Causal 
relationships were demonstrated in that pretreatment 
emotional distress significantly predicted post 
chemotherapy fatigue. 
Depression is a common but not universal reaction to 
cancer25. Depression is frequently underdiagnosed and 
undertreated in patients with cancer26 In addition, there 
was a significant relationship between catastrophizing 
and the psychological factors of depression and state- 
and trait anxiety in all cancer patients. 
Conclusion 
Therefore, according to the results of this research and 
other researches on the effectiveness of psychological 
interventions on chronic diseases, it is necessary to 
avoid medical treatments and by establishing 
counseling and psychotherapy centers and using 
psychological interventions in hospitals and oncology 
centers, in the process of Reduce depression and 
anxiety were helpful. 
References 
1. Bleiker EMA, Pouwer F, VanDerPloeg H, Leer J, Psychological 
distress two years after diagnosis of breast cancer: frequency and 
prediction. Patient Education and Counseling. 2000;40(3):209–17. 
2. Fortier MA, Wahi A, Bruce C, Maurer EL, Stevenson, R. Pain 
management at home in children with cancer: A daily diary study. 
Pediatric Blood & Cancer. 2014;61(6):1029. 
3. Fann J, Thomas-Rich R, Katon AM, Cowley WJ, Pepping D, 
McGregor M, et al. Major depression after breast cancer: A review of 
epidemiology and treatment. General Hospital Psychiatry, Medicine 
and Primary Care. 2008;30:112–6.  
4. Burgess C, Cornelius V, Love S, Graham J, Richards M, 
Ramirez A. Depression and anxiety in women with early breast 
cancer: Five-year observation of cohort study. British Medical 
Journal. 2005;330, 702.  
5. Hopwood P, Sump G, Mills J, Haviland J, Bliss JM. The course 
of anxiety and depression over the 5 years of follow up and risk 
Table 10: Comparison of post-test depression in two groups with control of pre-test effect. 
Source Df Mean Square F P-value Partial Eta Squared 
  
Pre-test 1 34.612 12.495 0.001 .252 
  
Group 1 10.750 3.881 0.045 0.391 
  
Error 37 2.770    
Total 40     
 
 
Asadbeygi et al.                         Assessing the effectiveness of cognitive behavioral stress management (CBSM) on anxiety … 
NBM                                                                            104                                   Novelty in Biomedicine 2018, 2, 99-104 
factors in women with early breast cancer: Results from the UK 
standardisation of Radiotherapy Trials (START). Breast. 
2010;19:84–91.  
6. Sollner W, Maislinger S, Konig A, Devries A, Lukas P. 
Providing psychological support for breast cancer patients based on 
screening for distress within a consultation-liaison service. Psycho-
Oncology. 2004;13:893–7.  
7. Stein KD, Syrjala KL, Andrykowski MA. Physical and 
psychological long-term and late effects of cancer. Cancer. 
2008;112(S11):2577-92. 
8. Yabroff KR, Lund J, Kepka D, Mariotto A. Economic burden 
of cancer in the United States: Estimates, projections, and future 
research. Cancer epidemiology, biomarkers & prevention: a 
publication of the American Association for Cancer Research, 
cosponsored by the American Society of Preventive Oncology. 
2011;20(10):2006-14. 
9. Henk HJ, Katzelnick DJ, Kobak KA, Greist JH, Jefferson JW. 
Medical costs attributed to depression among patients with a history 
of high medical expenses in a health maintenance organization. 
Arch Gen Psychiatry. 1996;53(10):899904. 
10. Kessler RC. The costs of depression. The Psychiatric clinics of 
North America. 2012;35(1):1-14. 
11. Brown LF, Kroenke K, Theobald DE, Wu J, Tu W. The 
association of depression and anxiety with health-related quality of 
life in cancer patients with depression and/or pain. Psychooncology. 
2010;19(7):734-41. 
12. Richardson A, Addington-Hall J, Amir Z, Foster C, Stark D, 
Armes J, et al. Ignorance and priorities for research in key areas of 
cancer survivorship: Findings from a scoping review. Br J Cancer. 
2011;105 Suppl 1:S82-9. 
13. Fortier MA, Wahi A, Bruce C, Maurer EL, Stevenson R. Pain 
management at home in children with cancer: A daily diary study. 
Pediatric Blood & Cancer. 2014;61(6):10291033.  
14. Jassim GA, Whitford DL, Grey I.M . Psychological 
interventions for women with nonmetastatic breast cancer. 
Cochrane Database of Systematic Reviews. 2010;10:1–10.  
15. Moyer A, Sohl SJ, Knapp-Oliver SK, Schneider S. 
Characteristics and methodological quality of 25 years of research 
investigating psychosocial intervention for cancer patients. Cancer 
Treatment Reviews. 2009;35:475–84.  
16. Redd WH, Montgomery GH, DuHammel KN. Behavioural 
intervention for cancer treatment side effects. Journal of the National 
Cancer Institute. 2001;93,810–823.  
17. Mundy EA, DuHamel KN, Montgomery GH. The efficacy of 
behavioural interventions for cancer treatment-related side effects. 
Seminars in Clinical Neuropsychiatry. 2003;8:253–75.  
18. Antoni MH, Lehman JM, Kilbourn KM, Boyers AE, Culver JL, 
Alferi SM, Carver CS. Cognitive-behavioral stress management 
intervention decreases prevalence of depression and enhances benefit 
finding among women under treatment for early-stage breast cancer. 
Health Psychology. 2001;20:20–32. 
19. Helgeson VS, Cohen S, Schultz R, Yasko J. Group support 
interventions for women with breast cancer: Who benefits from what? 
Health psychology. 2000;19:107–14.  
20. Andersen BL, Farrar WB, Goldenreutz DM, Glaser R, Emery 
CF, Crespin TR, et al. Psychological, behavioural and immune 
changes after a psychological intervention: A clinical trial. Journal of 
Clinical Oncology. 2004;23:6083–96.  
21. Tatrow K, Montgomery GH. Cognitive behaviouraltherapy 
techniques fordistress and pain in breast cancer patients: A meta-
analysis. Journal of Behavioural Medicine. 2006;29:17–27.  
22. Oliver S, Sohl S, Cannella D, Targhetta V. Preintervention 
distress moderates the efficacy of psychosocial treatment for cancer 
patients: A meta-analysis. Journal of Behavioural Medicine. 
2010;33:1–14.  
23. Hammen C. Stress and depression. Annual Review of Clinical 
Psychology. 2005;1:293–319. 
24. Liu RT LB. Stress generation in depression: a systematic review 
of the empirical literature and recommendations for future study. 
Clinical Psychology Review. 2010;30(5):582–93. 
25. Godding PR, McAnulty RD, Wittrock DA, Britt DM, Khansur T. 
Predictors of depression among male cancer patients. J Nerv Ment 
Dis. 1995;183:95–8. 
26. McDaniel JS, Musselman DL, Porter MR, Reed DA, Nemeroff 
CB. Depression in patients with cancer. Diagnosis, biology, and 
treatment. Arch Gen Psychiatry. 1995;52:89–99. 
 
 
 
 
 
 
 
 
 
 
 
 
 
